Clinical trials

An update on the impact of COVID-19 on the Fulcrum clinical trials

April 8, 2020 By Diana Kim-vdMeij

In the current global situation, it is also a challenge for companies like Fulcrum Therapeutics to continue clinical trials in times of the Covid-19 pandemic while protecting participants and clinical staff. Here is a brief update:Download